The Pharmaceutical 'Business With Disease'
The History Behind The ‘Business With Disease’
From the birth of IG Farben to ‘Arbeit Macht Frei’ to ‘Codex
Alimentarius’ the development of the ‘business with disease’ followed
a carefully planned route.
How The ‘Business With Disease’ Operates
The main principles governing the pharmaceutical “business with
Why The ‘Business With Disease’ Must Be Stopped
There is an entire industry with an innate economic interest to obstruct,
suppress and discredit any information about the eradication of diseases.
The pharmaceutical industry makes over one trillion dollars from selling
drugs for ongoing diseases. These drugs may relieve symptoms, but they
do not cure
The Dr Rath Health Foundation Vs The ‘Business With Disease’
Outlaw the 'Business with Disease': The Chemnitz Program
Liberating Human Health
The Health Movement Against Codex
Keeping watch on the activities of the ‘Business With Disease’
- Brussels EU Regulators Blatantly Ignoring Toxic Effects Of Pesticide Cocktails In Foods
- International Tribunal Accuses Monsanto Of Committing ‘Ecocide’
- Who Knows What’s Best For Your Children? You? Or The Government?
- Long-Term Use Of Antibiotics May Raise Risk Of Bowel Cancer
- Demise Of The Brussels EU Moves Closer: UK Government Issues Formal Notice Of Intention To Leave
- Death Of David Rockefeller At 101: Media Obituaries Ignore His Central Role In Bilderberg Group
- Study Finds High-Dose B Vitamins Have Protective Effect Against Air Pollution